BackChina SXT Pharmaceuticals Overview

China SXT Pharmaceuticals Receivables

China SXT Pharmaceuticals's receivables is $3.2M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$3.23M
↑ 70.11% YoYΔ $1.33M vs prior year quarter

Peer trimmed avg / median

Loading

China SXT Pharmaceuticals Receivables History

Loading

China SXT Pharmaceuticals vs. peers: Receivables Comparison

Loading

China SXT Pharmaceuticals Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

China SXT Pharmaceuticals (SXTC) FAQ

As of the most recent data (March 2026), SXTC shows a receivables of $3.2M. That compares with $1.9M in the prior-year period — up 70.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SXTC's receivables is now $3.2M (was $1.9M) — a 70.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether China SXT Pharmaceuticals is outperforming or lagging.

Tracking SXTC's receivables over time shows whether China SXT Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $3.2M That compares with $1.9M in the prior-year period — up 70.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has China SXT Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $3.2M) with ownership activity and broader fundamentals.

China SXT Pharmaceuticals's receivables is $3.2M; compare it with other Consumer Discretionary names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.